Evidence map›Paper›PMID 42283922›Full record

ArticleDiscover oncology2026

Revelations of pancreatic cancer treated by high-intensity focused ultrasound.

Wen Zhou, Cheng Lei, Xiaojing Xue, Hongfan Yu, Jian Li, Wenxi Li, Shizhu Li, Wei Xu, Min Li, Jing Li and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Wen Zhou *State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Cheng Lei *Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Xiaojing Xue *Department of Oncology, Mianyang Central Hospital, Mianyang, Sichuan, China.
Hongfan Yu *State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Jian LiSchool of Public Health, Chongqing Medical University, Chongqing, China.
Wenxi LiDepartment of Oncology, Mianyang Central Hospital, Mianyang, Sichuan, China.
Shizhu LiState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Wei XuSchool of Public Health, Chongqing Medical University, Chongqing, China.
Min LiState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Jing LiState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Qiulan ZhengDepartment of Nursing, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Miao HuangSchool of Nursing, Chongqing Medical University, Chongqing, China.
Yuxian NieState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Jin Bai *State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China. shajinbai@cqmu.edu.cn.
Gang Feng *Department of Oncology, Mianyang Central Hospital, Mianyang, Sichuan, China. fenggangmych@sina.com.
Xiuni Gan *Department of Nursing, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. 300650@cqmu.edu.cn.
Qiuling Shi *State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China. qshi@cqmu.edu.cn.

Funding

Cultivation plan for top-notch graduate students of Chongqing Medical University BJRC202424Foundation of State Key Laboratory of Ultrasound in Medicine and Engineering 2021KFKT011
6 · The paper itself

Abstract

backgroundPancreatic cancer remains among the most treatment-refractory solid malignancies worldwide. High-intensity focused ultrasound (HIFU) surgery is a treatment option with the advantage of providing cancer pain relief. However, there has been limited research addressing the trends in pancreatic cancer treatment utilizing HIFU surgery.

methodsPublications on pancreatic adenocarcinoma treatment utilizing HIFU surgery in the Web of Science Core Collection (WoSCC) were identified and analyzed by visualization software VOSviewer and CiteSpace. This approach provides comprehensive insights into the knowledge structure of the field.

resultsA total of 1172 articles published from 1999 to 2024 were identified in the WoSCC, showing a consistent rise in the publication volume and average annual citation frequency related to pancreatic adenocarcinoma treatment utilizing HIFU surgery. The United States and China contributed the most publications. There were six clusters summarized including descriptions of clinical trials of pancreatic cancer, basic research, mechanisms of HIFU surgery, combined therapy effect of pancreatic cancer, attenuated symptom of pancreatic cancer, and metastatic pancreatic cancer.

conclusionsBased on this bibliometric analysis of the publications over the last twenty years, it is the first scholarly visualization in the domain of pancreatic cancer treated with HIFU surgery. The clinical research regarding the efficacy of this technology should be developed in the future. It provides clinicians and researchers with a reliable synopsis, changes, and evolution regarding the field, offering a reference point for existing research and suggesting new avenues for future investigations.

Indexed as

BibliometricsHigh-Intensity Focused UltrasoundPancreatic cancerResearch progressTreatment

Identifiers

PMID42283922
PMCPMC13490040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.